Lacosam 50 Tablet contains Lacosamide 50 mg, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing without affecting normal neuronal excitability. This mechanism contributes to its efficacy in reducing seizure frequency. Lacosam 50 is typically administered orally and can be used as monotherapy or adjunctive therapy in adults and pediatric patients aged four years and above. The dosage should be individualized based on clinical response and tolerability, with a gradual titration recommended to minimize adverse effects. Common side effects may include dizziness, headache, nausea, and fatigue, while serious adverse reactions are rare but may involve cardiac conduction abnormalities; therefore, caution is advised in patients with pre-existing cardiac conditions. Lacosam 50 should be used under medical supervision, with regular monitoring to assess therapeutic efficacy and safety. It is contraindicated in patients with known hypersensitivity to lacosamide or any excipients. Patients should be counseled on adherence and potential interactions with other central nervous system depressants. Overall, Lacosam 50 provides an effective option for seizure management with a favorable safety profile.